Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.33 HKD 1.22%
Market Cap: 61.1B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

6
Current
7.9
Median
13.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
6
=
Enterprise Value
48.5B HKD
/
EBITDA
7.5B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
5.6
2-Years Forward
EV/EBITDA
5.2
3-Years Forward
EV/EBITDA
4.7

See Also

Discover More